Financials
Financial year 2024
PHARMIMPULSE from Lasne, company number BE0634979024, closed financial year 2024 with a result of € 0 after tax. For that financial year PHARMIMPULSE recorded a gross margin of € 842,528 and equity of € 3,750. Compared with financial year 2022, the result moved from € 0 to € 0. Around break-even. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 21, 2025.
€ 3,750
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 0
Profit after tax over the fiscal year.
€ 15,050
▼ 38% vs 2022
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 0.
People and assets in 2024
€ 837,838
▲ 18% vs 2022
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2024
€ 22,819
Loans from banks and other lenders, long and short.
€ 153,837
▲ € 120,123 vs 2022
Supplier invoices still open on the last day of the fiscal year.
€ 117,153
▼ 28% vs 2022
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2024 | Change 2022 → 2024 | |
|---|---|---|---|---|
| Gross margin | € 522,423 | € 715,651 | € 842,528 | ▲ 18% |
| Equity | € 3,750 | € 3,750 | € 3,750 | |
| Total debts | € 144,862 | € 216,214 | € 380,611 | ▲ 76% |
| Cash | € 22,837 | € 24,352 | € 15,050 | ▼ 38% |
| Bank debt | € 0 | € 0 | € 22,819 | |
| Balance sheet total | € 148,612 | € 219,964 | € 384,361 | ▲ 75% |
| Employees (FTE) | 11.2 | - | - |
Key figures of PHARMIMPULSE, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to PHARMIMPULSE?
What happened at PHARMIMPULSE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- PAUL RANSART stepped down as director. NBB
- New annual accounts for financial year 2024: profit of € 0. filed late Source: NBB ↗
- New establishment in Lasne. KBO
- PAUL RANSART became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 0 profit in 2021 to € 0 profit in 2024.
On average € 46,600 of value added per employee in 2021.
A new publication or filing at PHARMIMPULSE? We notify you, reason included.
Follow PHARMIMPULSEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of PALATINE, PHARMACIE DEFRE, envergure invest comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMIMPULSEThe shares are held by PALATINE (100%), PHARMACIE DEFRE (6.7%) and envergure invest (6.7%).
Directors
According to the 2024 annual accounts
PAUL RANSART
Manager
Also active at: COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE, PHARMACIE de BARRY, PALATINE, LENANS, IMMOLENANS, APOGREZ, ANCIAUX, LES PHARMACIES RURALES +15 more
since 2015 · until 2027
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue de la Bachée 86
1380 Lasne
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0634.979.024
- VAT number
- BE 0634.979.024
- Registered office
- Rue de la Bachée 86, 1380 Lasne
- Names & denominations
- PHARMIMPULSE
- Enterprise type
- Rechtspersoon
- Legal form
- General partnership
- Legal situation
- Normale toestand
- Start date
- 11 August 2015
- Peppol
- Active · Active since 31 Dec 2025
- Activities · NACE
Administratieve en ondersteunende activiteiten ten behoeve van kantoren
Activiteiten van uitzendbureaus en andere diensten in verband met personeelsvoorziening
Andere vormen van arbeidsbemiddeling
Overige zakelijke dienstverlening, neg
Diverse administratieve activiteiten ten behoeve van kantoren